Pharmacology, Toxicology and Pharmaceutical Science
Quinazoline
100%
Antitumor Activity
45%
Carbonate Dehydratase
41%
Breast Cancer
40%
Kidney Cancer
40%
Quinazolinone Derivative
40%
Antimicrobial Agent
34%
Quinazoline Derivative
34%
Binding Site
33%
Malignant Neoplasm
31%
IC50
31%
Epidermal Growth Factor Receptor
25%
Leukemia
24%
Antimicrobial Screening
23%
Neoplasm
23%
Theophylline Derivative
21%
Cytotoxicity
20%
Theophylline
20%
Adenosine Triphosphate
20%
Diuretic Activity
17%
Antiinflammatory Agent
17%
Analgesic Agent
17%
Non Small Cell Lung Cancer
17%
Isoenzyme
17%
Protein Tyrosine Kinase Inhibitor
17%
Sulfonamide
17%
Anticancer Screening
17%
Lewis Acid
17%
Antiinfective Agent
17%
Acetophenone Derivative
17%
Diuretics
17%
Lung Cancer
17%
Melanoma
14%
Celecoxib
11%
Diabetes Mellitus
11%
Phosphotransferase
11%
Anti-Inflammatory Drug
11%
Hyperglycemia
11%
Docetaxel
10%
Acetophenone
8%
Pharmaceutical Chemistry
8%
Acetamide
8%
Uterine Cervix Cancer
8%
Liver Cell Carcinoma
8%
Ovary Cancer
8%
N (5 Benzamido 4 Oxo 6 Phenylhexanoyl)proline
8%
Antiproliferative Activity
8%
Colon Carcinoma
8%
Erlotinib
8%
Curcumin
6%
Chemistry
Quinazoline
34%
Antimicrobial Screening
23%
Antimicrobial Agent
17%
Antiinfective
17%
Wavenumber
17%
Molecular Dynamics
17%
EC 3.4.21.5 (Thrombin) Inhibitor
17%
Thrombin
17%
Density Functional Theory
17%
Sulfonamide
17%
Dissociation Energy
17%
Kd
12%
Heterocyclic Compound
11%
Hyperpolarizability
8%
Hydrogen
8%
Hydrogen Atom
8%
Kinetics Measurement
8%
Attractive Force
8%
Molecular Orbital
8%
NMR Spectrum
8%
Thermodynamic Analysis
8%
Lowest Unoccupied Molecular Orbital
8%
Desolvation
8%
Natural Bond Orbital Analysis
8%
Molecular Geometry
8%
Crystal Structure
8%
Ionization Potential
8%
Electrostatic Potential
8%
DFT-B3LYP Calculation
8%
Carbonyl Group
8%
Autoxidation
8%
Nitrogen Atom
8%
Carbene
5%
Thiazolidinone
5%
Benzenesulfonamide
5%
Biochemistry, Genetics and Molecular Biology
Binding Site
23%
Thrombin
17%
Celecoxib
17%
Anticancer
17%
Cancer Cell
17%
In Silico Study
17%
Carbonic Anhydrase
17%
Docking (Molecular)
17%
Epidermal Growth Factor Receptor
17%
Active Site
14%
Hyperglycemia
11%
Glycerol
11%
Antiinflammatory Activity
8%
COX-2 Inhibitor
8%
Sulfonamide
8%
Isoform
8%
Selectivity Index
8%
IC50
8%
Analgesic Activity
8%
Plant Extract
5%
Antineoplastic Activity
5%
Lipid
5%
Infrared Radiation
5%
Cytotoxicity
5%
Metabolite
5%
Solution and Solubility
5%
Molecular Model
5%
Glucosidase
5%
Streptozotocin
5%
Glucoside
5%
Koji
5%
Glucose Blood Level
5%
Liquid Chromatography-Mass Spectrometry
5%
